Andere talen Burning Rock Biotech Limited

Aandelen

BNR

US12233L1070

Vertraagde tijd Nasdaq Andere beurzen 17:09:33 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,8201 ^USD	+2,51%		+7,91%	-11,82%

02/04	Earnings Flash (BNR.L) BURNING ROCK BIOTECH boekt $75,7M omzet over boekjaar 2013	MT
29/03	Transcript : Burning Rock Biotech Limited, Q4 2023 Earnings Call, Mar 29, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M	02/04
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90	02/04
Burning Rock Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/03
Earnings Flash (BNR) BURNING ROCK BIOTECH LIMITED Posts Q4 Revenue RMB121.1M	28/03
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results	28/03
Burning Rock Announces Receipt of Notification from NASDAQ	04/01
Burning Rock Biotech Receives Nasdaq Listing Requirement Notice	04/01
Burning Rock Biotech Gets Non-Compliance Notice From Nasdaq	04/01
Burning Rock Announces Results of 2023 Annual General Meeting	20/12
MORNING BID AMERICAS-November bids adieu with inflation data, OPEC	30/11
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11
Burning Rock Reports Third Quarter 2023 Financial Results	30/11
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023	22/11
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023	21/11
Burning Rock, Boehringer Ingelheim Unveil Agreement Targeting Oncology Companion Diagnostics	30-10-23
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics	30-10-23
Burning Rock and Boehringer Ingelheim Achieves Master Service Agreement in Oncology Companion Diagnostics	30-10-23
Burning Rock Biotech Receives Breakthrough Device Designation in China for Multi-cancer Test	16-10-23
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test	16-10-23
Burning Rock Biotech Limited Receives Breakthrough Device Designation from China?s NMPA for its Multi-Cancer Early Detection Test	16-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Burning Rock Biotech Limited

Aandelen

BNR

US12233L1070

Andere talen

Filters